UK markets close in 5 hours 49 minutes

CSPC Pharmaceutical Group Limited (CHJTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.75000.0000 (0.00%)
At close: 02:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.85B
Enterprise value 8.14B
Trailing P/E 10.98
Forward P/E 10.24
PEG ratio (5-yr expected) 2.73
Price/sales (ttm)2.05
Price/book (mrq)1.95
Enterprise value/revenue 0.26
Enterprise value/EBITDA 0.95

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-24.24%
S&P500 52-week change 323.57%
52-week high 30.9900
52-week low 30.6400
50-day moving average 30.7862
200-day moving average 30.7819

Share statistics

Avg vol (3-month) 33.42k
Avg vol (10-day) 33.8k
Shares outstanding 511.9B
Implied shares outstanding 613.14B
Float 88.26B
% held by insiders 129.79%
% held by institutions 132.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.04
Forward annual dividend yield 44.77%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 333.87%
5-year average dividend yield 4N/A
Payout ratio 446.38%
Dividend date 3N/A
Ex-dividend date 431 May 2024
Last split factor 26:5
Last split date 318 Jun 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 18.67%
Operating margin (ttm)23.59%

Management effectiveness

Return on assets (ttm)9.96%
Return on equity (ttm)18.22%

Income statement

Revenue (ttm)31.45B
Revenue per share (ttm)2.65
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)N/A
EBITDA 7.93B
Net income avi to common (ttm)5.87B
Diluted EPS (ttm)0.0700
Quarterly earnings growth (yoy)-15.10%

Balance sheet

Total cash (mrq)13.76B
Total cash per share (mrq)1.16
Total debt (mrq)706.9M
Total debt/equity (mrq)2.02%
Current ratio (mrq)2.63
Book value per share (mrq)2.80

Cash flow statement

Operating cash flow (ttm)4.18B
Levered free cash flow (ttm)1.16B